Form 8-K Cartesian Therapeutics, For: Oct 15
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Cartesian Therapeutics eliminates chief scientific officer position
October 21, 2025 7:04 AM EDTCartesian Therapeutics Inc. (NASDAQ: RNAC) eliminated the chief scientific officer position and terminated Christopher Jewell without cause, effective November 14, 2025, according to a company statement.
The company delivered the termination notice to Jewell on October 15, 2025. Jewell entered into a separation agreement with Cartesian Therapeutics on... More
